About CDx Diagnostics
CDx Diagnostics is a company based in Suffern (United States) founded in 1997 by Mark Rutenberg was acquired by Galen Partners in July 2017.. CDx Diagnostics has raised $16.04 million across 2 funding rounds from investors including Galen Partners. CDx Diagnostics offers products and services including WATS 3D, OralCDx, and EndoCDx. CDx Diagnostics operates in a competitive market with competitors including Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and PathAI, among others.
- Headquarter Suffern, United States
- Founders Mark Rutenberg
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$16.04 M (USD)
in 2 rounds
-
Latest Funding Round
$5 M (USD), Series A
Jun 15, 2020
- Investors
-
Employee Count
Employee Count
-
Acquired by
Galen Partners
(Jul 11, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CDx Diagnostics
CDx Diagnostics offers a comprehensive portfolio of products and services, including WATS 3D, OralCDx, and EndoCDx. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI-enabled tool for early detection of precancerous cells in esophagus.
Platform for oral cancer prevention through advanced tissue analysis.
Technology for detecting dysplasia in endoscopic procedures.
Unlock access to complete
Unlock access to complete
Funding Insights of CDx Diagnostics
CDx Diagnostics has successfully raised a total of $16.04M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5 million completed in June 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $5.0M
-
First Round
First Round
(16 Dec 2019)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2020 | Amount | Series A - CDx Diagnostics | Valuation |
investors |
|
| Dec, 2019 | Amount | Series A - CDx Diagnostics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CDx Diagnostics
CDx Diagnostics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Galen Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm investing in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CDx Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CDx Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cdx Diagnostics Comparisons
Competitors of CDx Diagnostics
CDx Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and PathAI, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| domain | founded_year | HQ Location |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cdx Diagnostics
Frequently Asked Questions about CDx Diagnostics
When was CDx Diagnostics founded?
CDx Diagnostics was founded in 1997 and raised its 1st funding round 22 years after it was founded.
Where is CDx Diagnostics located?
CDx Diagnostics is headquartered in Suffern, United States. It is registered at Suffern, New York, United States.
Is CDx Diagnostics a funded company?
CDx Diagnostics is a funded company, having raised a total of $16.04M across 2 funding rounds to date. The company's 1st funding round was a Series A of $11.04M, raised on Dec 16, 2019.
What does CDx Diagnostics do?
CDx Diagnostics was founded in 1997 and is headquartered in Suffern, United States. The company operates in the healthcare diagnostics sector, focusing on AI-driven technologies for early detection of precancerous conditions. Proprietary WATS3D biopsy platform is employed to identify tissue changes. Key products include OralCDx, a non-invasive oral brush biopsy system, and EndoCDx, a transepithelial laryngeal brush biopsy tool, supporting clinical assessments in oncology-related fields.
Who are the top competitors of CDx Diagnostics?
CDx Diagnostics's top competitors include Juno Therapeutics, Poseida Therapeutics and PathAI.
What products or services does CDx Diagnostics offer?
CDx Diagnostics offers WATS 3D, OralCDx, and EndoCDx.
Who are CDx Diagnostics's investors?
CDx Diagnostics has 1 investor. Key investors include Galen Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.